Workflow
Lubrizol
icon
Search documents
Berkshire Hathaway to buy Occidental Petroleum's chemicals arm for $9.7B
Fox Businessยท 2025-10-02 20:35
Core Viewpoint - Occidental Petroleum is divesting its chemicals arm OxyChem to Berkshire Hathaway for $9.7 billion to reduce debt after significant acquisitions [1][5]. Group 1: Transaction Details - The sale of OxyChem marks Occidental's largest divestment to date, aimed at slashing its debt load [1]. - OxyChem generated combined revenue of $2.42 billion in the first half of the year, producing chemicals for swimming pools and medical supplies [3]. - The deal is expected to close in the fourth quarter and will be Berkshire's largest acquisition since its $11.6 billion purchase of Alleghany Corporation in 2022 [3][10]. Group 2: Financial Implications - Analysts have expressed concerns that the sale could negatively impact Occidental's free cash flow growth in the coming years, as OxyChem was anticipated to contribute significantly to expansion [2]. - The transaction price of $9.7 billion is viewed as low compared to previous estimates of OxyChem's value at $12 billion [2]. - Occidental plans to use $6.5 billion of the proceeds from the sale to reduce its debt, aiming to bring total principal debt below the $15 billion target set after the CrownRock acquisition [9]. Group 3: Strategic Focus - The divestment indicates Occidental's strategic refocus on its core oil and gas business, which accounted for 75% of its total earnings last year [10]. - CEO Vicki Hollub stated that the sale would enable the company to "unlock 20-plus years of low-cost resource runway" in oil and gas [11]. Group 4: Background Context - Berkshire Hathaway is Occidental's largest shareholder, having begun acquiring a stake in the company in February 2022 [4]. - The divestment follows Occidental's $55 billion acquisition of Anadarko Petroleum, which left the company with significant debt [5][8].